Rob Binns
Directeur Financier/CFO chez HOPEFIELD VENTURES TWO INC.
Fortune : 29 500 $ au 31/05/2024
Profil
Rob Binns is currently the Chief Financial Officer at Hopefield Ventures Two, Inc. He previously worked as the General Manager-Prince Edward Operations at Genzyme Corp., the Chief Operating Officer at Diagnostic Chemicals Ltd., the Chief Financial Officer at ScreenScape Networks, Inc., and the Controller at BioVectra, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/01/2023 | 500 000 ( 5,89% ) | 29 500 $ | 31/05/2024 |
Postes actifs de Rob Binns
| Sociétés | Poste | Début |
|---|---|---|
| HOPEFIELD VENTURES TWO INC. | Directeur Financier/CFO | - |
Anciens postes connus de Rob Binns
| Sociétés | Poste | Fin |
|---|---|---|
ScreenScape Networks, Inc.
 ScreenScape Networks, Inc. Internet Software/ServicesTechnology Services ScreenScape Networks, Inc. develops digital signage software that helps businesses connect and control screens over the Internet. Its customers can turn any screen into a connected digital sign by using plug and play device. The firm’s platform is used by the brand makers and retail networks to publish digital signage content on screens inside their stores. The company was founded by Mark Hemphill in 2007 and is headquartered in Charlottetown, Canada. | Directeur Financier/CFO | - |
Diagnostic Chemicals Ltd.
 Diagnostic Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Diagnostic Chemicals Ltd. manufactures pharmaceutical products. The private company is based in Charlottetown, Canada. | Directeur des opérations | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
BioVectra, Inc.
 BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Comptroller/Controller/Auditor | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Diagnostic Chemicals Ltd.
Diagnostic Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Diagnostic Chemicals Ltd. manufactures pharmaceutical products. The private company is based in Charlottetown, Canada. | Health Technology |
ScreenScape Networks, Inc.
ScreenScape Networks, Inc. Internet Software/ServicesTechnology Services ScreenScape Networks, Inc. develops digital signage software that helps businesses connect and control screens over the Internet. Its customers can turn any screen into a connected digital sign by using plug and play device. The firm’s platform is used by the brand makers and retail networks to publish digital signage content on screens inside their stores. The company was founded by Mark Hemphill in 2007 and is headquartered in Charlottetown, Canada. | Technology Services |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Health Technology |
| Hopefield Ventures Two, Inc. |
